This is a Validated Antibody Database (VAD) review about mouse Mapk7, based on 14 published articles (read how Labome selects the articles), using Mapk7 antibody in all methods. It is aimed to help Labome visitors find the most suited Mapk7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mapk7 synonym: BMK-1; BMK1; ERK-5; ERK5; Erk5-T; PRKM7; b2b2346Clo

Abcam
domestic rabbit polyclonal
  • western blot; human; fig 3
Abcam Mapk7 antibody (Abcam, ab196609) was used in western blot on human samples (fig 3). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EP791Y)
  • western blot; human; 1:1000
Abcam Mapk7 antibody (Abcam, ab40809) was used in western blot on human samples at 1:1000. J Cell Biochem (2015) ncbi
R&D Systems
domestic goat polyclonal
  • immunoprecipitation; human; fig 5e
In order to study the role of statin and ERK5 in tight junction formation and function in endothelial cells, R&D Systems Mapk7 antibody (R&D systems, AF2848) was used in immunoprecipitation on human samples (fig 5e). J Cell Physiol (2018) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6f
In order to demonstrate that TORC1 is important for proteasome homeostasis, MilliporeSigma Mapk7 antibody (Sigma, E1523) was used in western blot on human samples at 1:1000 (fig 6f). Nature (2016) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5d
Cell Signaling Technology Mapk7 antibody (Cell Signaling, 3371) was used in western blot on mouse samples (fig 5d). JACC Basic Transl Sci (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3c
Cell Signaling Technology Mapk7 antibody (Cell Signaling, 3372) was used in western blot on human samples at 1:1000 (fig s3c). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology Mapk7 antibody (Cell signaling, 3371) was used in western blot on human samples (fig 6e). PLoS Biol (2018) ncbi
domestic rabbit monoclonal (D23E9)
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology Mapk7 antibody (Cell signaling, 3552) was used in western blot on human samples (fig 6e). PLoS Biol (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2a
Cell Signaling Technology Mapk7 antibody (Cell Signaling, 3372) was used in western blot on mouse samples at 1:1000 (fig 2a). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Mapk7 antibody (Cell Signaling, 3371) was used in western blot on human samples (fig 5d). Mol Oncol (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 7
  • western blot; human; fig 1b
In order to study the role of statin and ERK5 in tight junction formation and function in endothelial cells, Cell Signaling Technology Mapk7 antibody (New England Biolabs, 3372) was used in immunocytochemistry on human samples (fig 7) and in western blot on human samples (fig 1b). J Cell Physiol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3a
In order to study the role of statin and ERK5 in tight junction formation and function in endothelial cells, Cell Signaling Technology Mapk7 antibody (New England Biolabs, 3371) was used in western blot on human samples (fig 3a). J Cell Physiol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology Mapk7 antibody (Cell Signaling Technology, 3372) was used in western blot on human samples (fig 6d). Biochim Biophys Acta (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Mapk7 antibody (Cell Signaling Technology, 3371) was used in western blot on human samples (fig 2f). Biochim Biophys Acta (2016) ncbi
domestic rabbit monoclonal (D23E9)
  • western blot; human; fig s7
  • western blot; mouse; fig 3
In order to analyze the rescue of intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation due to ERK5 signaling, Cell Signaling Technology Mapk7 antibody (Cell signaling, D23E9) was used in western blot on human samples (fig s7) and in western blot on mouse samples (fig 3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8c
In order to assess the contribution of MEK5/ERK5 signaling in the sensitivity of colon cancer cells to 5-fluorouracil, Cell Signaling Technology Mapk7 antibody (Cell Signaling Technology, 3372) was used in western blot on human samples (fig 8c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D23E9)
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology Mapk7 antibody (Cell Signaling Technology, 3552) was used in western blot on human samples at 1:1000 (fig s1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D23E9)
  • western blot; human; fig 3
Cell Signaling Technology Mapk7 antibody (Cell Signaling, 3552) was used in western blot on human samples (fig 3). BMC Cancer (2015) ncbi
Articles Reviewed
  1. Guo X, Kolpakov M, Hooshdaran B, Schappell W, Wang T, Eguchi S, et al. Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload. JACC Basic Transl Sci. 2020;5:69-83 pubmed publisher
  2. Kennedy S, Jarboui M, Srihari S, Raso C, Bryan K, Dernayka L, et al. Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D. Nat Commun. 2020;11:499 pubmed publisher
  3. Tan P, Ye Y, He L, Xie J, Jing J, Ma G, et al. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. PLoS Biol. 2018;16:e3000051 pubmed publisher
  4. Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, et al. Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. Proc Natl Acad Sci U S A. 2018;115:E2801-E2810 pubmed publisher
  5. Baumann C, Ullrich A, Torka R. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Mol Oncol. 2017;11:1430-1447 pubmed publisher
  6. Wilkinson E, Sidaway J, Cross M. Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells. J Cell Physiol. 2018;233:186-200 pubmed publisher
  7. Rousseau A, Bertolotti A. An evolutionarily conserved pathway controls proteasome homeostasis. Nature. 2016;536:184-9 pubmed
  8. Shi K, Qian J, Qi L, Mao D, Chen Y, Zhu Y, et al. Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-?B activation in HCAECs. Oncol Lett. 2016;12:1438-1444 pubmed
  9. Im J, Yoon S, Kim B, Ban H, Won K, Chung K, et al. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes ?-catenin-mediated invasion. Biochim Biophys Acta. 2016;1859:1449-1458 pubmed publisher
  10. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  11. Pereira D, Simões A, Gomes S, Castro R, Carvalho T, Rodrigues C, et al. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism. Oncotarget. 2016;7:34322-40 pubmed publisher
  12. Qiu Z, Sun R, Mo X, Li W. The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth. PLoS ONE. 2016;11:e0147185 pubmed publisher
  13. Gavine P, Wang M, Yu D, Hu E, Huang C, Xia J, et al. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma. BMC Cancer. 2015;15:454 pubmed publisher
  14. Zuo Y, Wu Y, Wehrli B, Chakrabarti S, Chakraborty C. Modulation of ERK5 is a novel mechanism by which Cdc42 regulates migration of breast cancer cells. J Cell Biochem. 2015;116:124-32 pubmed publisher